MyFinsight
Home
About
Contact
apre: the income statement
Download
Download image
Total comprehensive
loss
-$2,973,527
(20.92%↑ Y/Y)
Interest income, net
$150,669
(-56.80%↓ Y/Y)
Foreign currency
translation
-$1,117
(-104.74%↓ Y/Y)
Net loss
-$2,972,410
(21.44%↑ Y/Y)
Total other income
$144,978
(-53.72%↓ Y/Y)
Foreign currency (loss)
gain
-$5,691
(83.97%↑ Y/Y)
Loss from operations
-$3,117,388
(23.91%↑ Y/Y)
Grant revenue
$1,848
(-99.48%↓ Y/Y)
Total operating
expenses
$3,119,236
(-29.93%↓ Y/Y)
General and
administrative
$1,480,319
(-7.78%↓ Y/Y)
Research and development
$1,638,917
(-42.42%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)